Gairdner Science Week Symposium
Featuring 2021 Canada Gairdner Award Laureates Mary-Claire King and Elizabeth Eisenhauer, and international research leaders Charles Swanton (Francis Crick Institute, UK), Sam Aparicio (UBC, Canada), Nada Jabado (McGill, Canada) and others.
12:00 pm Introduction & Welcome
Dr. Janet Rossant, President & Scientific Director, The Gairdner Foundation
Session 1. Chair: Dr. Jim Woodgett, Terry Fox Research Institute
12:05 pm How Heritable Cancer Mutations Inform All Cancer Treatments.
Dr. Mary-Claire King, 2021 Canada Gairdner International Award laureate; University of Washington, Seattle, Washington, USA
12:25 pm Tumour Heterogeneity and Tumour Evolution.
Dr. Charles Swanton, The Francis Crick Institute, London, United Kingdom
12:45 pm Molecular Taxonomy of Breast Cancer and Next-Generation Treatments.
Dr. Sam Aparicio, University of British Columbia, Vancouver, British Columbia Canada
1:05 pm Cancer Epigenetics, Early Detection and Epigenetic Therapies.
Dr. Daniel De Carvalho, Princess Margaret Cancer Centre; the University of Toronto, Toronto, Ontario, Canada
1:25 pm BREAK
Session 2. Chair: Dr. Lillian Siu, Princess Margaret Cancer Centre, UHN, Toronto.
1:40 pm Genetics and Epigenetics of Childhood Brain Tumours.
Dr. Nada Jabado, McGill University, Montreal, Quebec, Canada
2:00 pm Cycling Cancer Persister Cells: Lineage Relationships and Non-genetic Mechanisms.
Dr Aviv Regev, Genentech, South San Francisco, California.
2:20 pm Driving Innovation and Partnerships in Canadian Clinical Trials.
Dr. Elizabeth Eisenhauer, 2021 Canada Gairdner Wightman Award laureate; Queen’s University, Kingston, Ontario, Canada
2:40 pm Roundtable Discussion With All Speakers
Moderated by Dr. Victor Ling.
3:30 pm Event concludes